FORBES RICHEST - 100 INDIANS LIST - 2019

FORBES RICHEST

100 INDIANS LIST 2019

Forbes has released the 2019 India Rich list which is compiled using data from shareholding and financial information obtained from families and individuals, stock exchanges, analysts and Indian regulatory agencies.

The total wealth of the tycoons on the 2019 Rich List decreased by 8% to $452 billion from a year ago.  

Mukesh Ambani is the RICHEST INDIAN and there is huge gap between him and the Rest.

Ratan TATA is not in the List as his properties are in the name of Trusts.

Azim Premji of Wipro is now at 17 as he has been donating his incomes frequently.

Mukesh Ambani's JIO is moving ahead in Telecom. As the latest entrant in Telecom, it has no Old baggage and is beneficiary of all moves in Telecom Industry. Others were languishing but are now likely to become profitable after Tariff revision.

Infosys founders are mostly in this list. I don’t know if anybody has missed out.

 

Rank	Name	Net Worth (In $ Billion)	Company		Age
1	Mukesh Ambani	51.4	Reliance Industries		62
2	Gautam Adani	15.7	Adani Ports & SEZ		57
3	Hinduja brothers	15.6	Ashok Leyland		83, 78, 73, 68
4	Pallonji Mistry	15	Shapoorji Pallonji Group		90
5	Uday Kotak	14.8	Kotak Mahindra Bank		60
6	Shiv Nadar	14.4	HCL Technologies		74
7	Radhakishan Damani	14.3	Avenue Supermarts		64
8	Godrej family	12	Godrej Group		NA
9	Lakshmi Mittal	10.5	ArcelorMittal		69
10	Kumar Mangalam Birla	9.6	Aditya Birla Group		52
11	Bajaj family	9.2	Bajaj Auto		NA
12	Cyrus Poonawalla	9.1	Serum Institute of India		78
13	Burman family	8.3	Dabur		NA
14	Sunil Mittal	7.6	Bharti Airtel		62
15	Dilip Shanghvi	7.55	Sun Pharmaceutical Industries		63
16	Madhukar Parekh	7.5	Pidilite Industries		73
17	Azim Premji	7.2	Wipro		74
18	Nusli Wadia	7.1	Britannia Industries		75
19	Benu Gopal Bangur	6.3	Shree Cement		88
20	Savitri Jindal	5.8	O.P. Jindal Group		69
21	Kuldip & Gurbachan Singh Dhingra	5.5	Berger Paints India
22	Kapil & Rahul Bhatia	5.4	Interglobe Aviation		87, 59
23	Ashwin Dani	4.8	Asian Paints		76
24	Harsh Mariwala	4.6	Marico		68
25	Kushal Pal Singh	4.35	DLF		88
26	M.A. Yusuff Ali	4.3	LuLu Group		63
27	Sudhir & Samir Mehta	4.15	Torrent Group		65, 56
28	Hasmukh Chudgar	4.1	Intas Pharmaceuticals		86
29	Vinod & Anil Rai Gupta	4	Havells India		74, 50
30	Karsanbhai Patel	3.9	Nirma		75
31	Mahendra Choksi	3.85	Asian Paints		78
32	Vikram Lal	3.8	Eicher Motors		77
33	Micky Jagtiani	3.7	Landmark Group		68
34	Pawan Munjal	3.65	Hero MotoCorp		65
35	Abhay Vakil	3.5	Asian Paints		68
36	Rajendra Agarwal	3.45	Macleods Pharmaceuticals		60
37	Murali Divi	3.4	Divi's Laboratories		68
38	Anil Agarwal	3.35	Vedanta Resources		66
39	P.P. Reddy	3.3	Megha Engineering & Infrastructure		62
40	Chandru Raheja	3.2	K. Raheja Corp		79
41	Singh family	3.18	Alkem Laboratories		NA
42	B.R. Shetty	3.15	NMC Health		77
43	Ravi Pillai	3.1	RP Group		66
44	M.G. George Muthoot	3.05	Muthoot Finance		69
45	Ajay Piramal	2.95	Piramal Enterprises		64
46	Pankaj Patel	2.8	Cadila Healthcare		66
47	Mangal Prabhat Lodha	2.65	Lodha Group		63
48	Rakesh Jhunjhunwala	2.6	Rare Enterprises		59
49	Kalanithi Maran	2.5	Sun TV Network		54
50	Jitendra Virwani	2.48	Embassy Property Development		53
51	N.R. Narayana Murthy	2.47	Infosys		73
52	Vivek Chaand Sehgal	2.45	Motherson Sumi Sytems		63
53	Ravi Jaipuria	2.4	RJ Corp		64
54	Kiran Mazumdar-Shaw	2.38	Biocon		66
55	Senapathy Gopalakrishnan	2.36	Infosys		64
56	Vijay Shekhar Sharma	2.35	Paytm		41
57	Shashi & Ravi Ruia	2.33	Essar Group		75, 70
58	Ramesh Juneja	2.3	Mankind Pharma		66
59	P.V. Ramprasad Reddy	2.25	Aurobindo Pharma		61
60	Rajan Raheja	2.22	Exide Industries		65
61	Gupta family	2.2	Lupin		NA
62	Abhay Firodia	2.12	Force Motors		74
63	Vikas Oberoi	2.11	Oberoi Realty		49
64	Amalgamations Group family	2.1	Tractors & Farm Equipment		NA
65	Murugappa family	2.09	Murugappa Group		NA
66	Baba Kalyani	2.07	Bharat Forge		70
67	Sunny Varkey	2.05	GEMS Education		62
68	Shyam & Hari Bhartia	2	Jubilant Group		66, 62
69	Vijay Chauhan	1.95	Parle Products		83
70	Salil Singhal	1.93	PI Industries		72
71	Leena Tewari	1.92	USV India		62
72	Byju Raveendran	1.91	Byju's		38
73	Sunder Genomal	1.9	Page Industries		65
74	Yusuf Hamied	1.89	Cipla		83
75	Mofatraj Munot	1.85	Kalpataru		74
76	Sridhar Vembu	1.83	Zoho		51
77	Harsh Goenka	1.82	RPG Group		61
78	Nandan Nilekani	1.81	Infosys		64
79	Sanjiv Goenka	1.8	RP-Sanjiv Goenka Group		58
80	Kishore Biyani	1.78	Future Group		58
81	Mahendra Prasad	1.77	Aristo Pharmaceuticals		79
82	Reddy family	1.76	Dr. Reddy's Laboratories		NA
83	Jain family	1.75	Bennett Coleman & Co.		NA
84	Anurang Jain	1.74	Endurance Technologies		57
85	Devendra Jain	1.73	Gujarat Fluorochemicals		90
86	Manohar Lal & Madhusudan Agarwal	1.7	Haldiram Snacks
87	Rajju Shroff	1.69	UPL		85
88	Anand Mahindra	1.65	Mahindra & Mahindra		64
89	K. Dinesh	1.61	Infosys		65
90	Sunil Vaswani	1.6	Stallion Group		56
91	Lachhman Das Mittal	1.59	Sonalika Group		88
92	Ranjan Pai	1.58	Manipal Group		46
93	Rajesh Mehta	1.57	Rajesh Exports		55
94	Bhavin & Divyank Turakhia	1.54	Media.net		39, 37
95	Rajesh Mehra	1.5	Jaquar Group		61
96	Bhadresh Shah	1.49	AIA Engineering		67
97	Acharya Balkrishna	1.47	Patanjali Ayurved		47
98	Sandeep Engineer	1.45	Astral Poly Technik		58
99	Shamsheer Vayalil	1.41	VPS Healthcare		42
100	S.D. Shibulal	1.4	Infosys		64

IOL Chemicals and Pharmaceuticals Ltd - Q2 FY 20 RESULTS - REVIEW

IOL Chemicals and Pharmaceuticals Ltd

Q2 FY 20 RESULTS - REVIEW

About IOL Chemicals and Pharmaceuticals Limited (IOLCP)

Company was established in 1986 is one of the leading Active Pharmaceutical ingredients/ bulk drugs manufacturing Company and is a significant player in the specialty chemicals space with world class facilities. 

IOLCP  has wide presence across  major therapeutic categories  like,  Pain Management, anti-convulsants, anti-diabetes, anti- cholesterol and anti-platelets. 

IOLCP's  product  portfolio  includes  Active Pharmaceutical lngredients;   Ibuprofen,   Metformin,   Fenofibrate, Clopidogrel,  Lamotrigine,  Pantoprazole  and  specialty  chemicals  such  as  Ethyl Acetate,  lso Butyl Benzene, Mono Chiaro Acetic Acid and Acetyl Chloride. 

Company is World's largest producer of the Ibuprofen with an installed capacity of 12,000 TPA and  having backward  integrated manufacturing facility.  

The Company has DSIR approved R&D which is fully equipped to validate existing processes. 

The Central  and  State  Government approved  Effluent Treatment Plant (ETP)  had been  set up  with  zero  effluent discharge  system  along with  17  MW  captive  Co- Generation plant for self reliance. 

IOLCP's overseas customers are spread out across several  countries including UK, Austria, Belgium,  Hungry,  Spain, Germany,  Italy, Netherlands,  Switzerland, Portugal, Poland,  Ireland,  USA,  Australia,  Chile,  Peru,  Brazil,  Argentina,  Colombia,  Mexico, Indonesia,  South  Korea,  Thailand  etc.  

Products  are  sold  primarily  to  Branded Generic formulators both in India & Overseas

IOL has posted remarkable operational and financial performance for the second quarter of financial year 2019-20. It was after a consistent first quarter performance.

Quarter ended September 2019 vis a vis Quarter ended September 2018 

• Income from operations increased by 5 % to~Rs.452 crore from Rs.429 crore.

• EBIDTA increased by 68 % to~Rs.136 crore from Rs.81 crore.

• Net Profit increased by 132 % to~Rs.88 crore from Rs.38 crore.

• EPS increased by 125 % to Rs.15.42 from Rs.6.84.

Half year ended September 2019 vis a vis Half year ended September 2018 

• Income from operations increased by 19 % to~ 948 crore from Rs.794 crore.

• EBIDTA increased by 129 % to Rs.284 crore from Rs.124 crore.

• Net Profit increased by 226 % to Rs.173 crore from Rs.53 crore.

• EPS increased by 224 % to Rs.30.42 from Rs.9.40. 

Mr Vijay Garg, Joint Managing Director said :

"We are very delighted to announce consistently strong operational and financial performance during the 2ndquarter of the Financial Year 2019-20. 

We have successfully set up Unit VI to manufacture Pantoprazole with a capacity of 240 MT per annum which will enable to increase the revenue of the Company. 

He further added, we have made the pre-payment of term loan of aggregate amount of Rs.161.44 crore till date to reduce the financial cost of the Company."